This is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 “harvest” have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules
Combination drugs are an important class of US FDA approved pharmaceuticals. These drugs have been o...
The pharmaceutical industry is defined as the discovery, development and production of drugs and med...
Biologics — biomolecule-based therapeutics — are predicted to become the next generation of therapeu...
This is an analysis from a chemical point of view of the 46 drugs (34 New Chemical Entities and 12 B...
The Food and Drug Administration approved 59 new drugs (42 New Chemical Entities and 17 Biologics) d...
Similar to last year, 2021 will be remembered for the COVID-19 pandemic. Although five vaccines have...
While 2021 ended with the world engulfed in the COVID-19 Omicron wave, 2022 has ended in almost all ...
From the medical, pharmaceutical, and social perspectives, 2021 has been a year dominated by the COV...
2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the F...
In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, thre...
In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, thre...
New drugs introduced to the market every year represent privileged structures for particular biologi...
From the medical, pharmaceutical, and social perspectives, 2021 has been a year dominated by the COV...
2019 has been an excellent year in terms of peptides and oligonucleotides (TIDES) approved by the FD...
<p>Based on the 432 new molecular entities (with at least one patent) approved by the U.S. Food and ...
Combination drugs are an important class of US FDA approved pharmaceuticals. These drugs have been o...
The pharmaceutical industry is defined as the discovery, development and production of drugs and med...
Biologics — biomolecule-based therapeutics — are predicted to become the next generation of therapeu...
This is an analysis from a chemical point of view of the 46 drugs (34 New Chemical Entities and 12 B...
The Food and Drug Administration approved 59 new drugs (42 New Chemical Entities and 17 Biologics) d...
Similar to last year, 2021 will be remembered for the COVID-19 pandemic. Although five vaccines have...
While 2021 ended with the world engulfed in the COVID-19 Omicron wave, 2022 has ended in almost all ...
From the medical, pharmaceutical, and social perspectives, 2021 has been a year dominated by the COV...
2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the F...
In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, thre...
In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, thre...
New drugs introduced to the market every year represent privileged structures for particular biologi...
From the medical, pharmaceutical, and social perspectives, 2021 has been a year dominated by the COV...
2019 has been an excellent year in terms of peptides and oligonucleotides (TIDES) approved by the FD...
<p>Based on the 432 new molecular entities (with at least one patent) approved by the U.S. Food and ...
Combination drugs are an important class of US FDA approved pharmaceuticals. These drugs have been o...
The pharmaceutical industry is defined as the discovery, development and production of drugs and med...
Biologics — biomolecule-based therapeutics — are predicted to become the next generation of therapeu...
DOI
Add to ORKG